作者:
Bart,P.-A. [1]
;
Huang,Y. [2]
;
Karuna,S.T. [3]
;
Chappuis,S. [4]
;
Gaillard,J. [5]
;
Kochar,N. [6]
;
Shen,X. [7]
;
Allen,M.A. [8]
;
Ding,S. [9]
;
Hural,J. [10]
;
Liao,H.-X. ;
Haynes,B.F. ;
Graham,B.S. ;
Gilbert,P.B. ;
McElrath,M.J. ;
Montefiori,D.C. ;
Tomaras,G.D. ;
Pantaleo,G. ;
Frahm,N.
作者单位:
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave
[1]
EuroVacc FoundationLausanne, Switzerland
[2]
Duke University Medical Center, Duke Human Vaccine InstituteDurham, NC, United States
[3]
NIAID, NIHBethesda, MD, United States
[4]
Service of Immunology and Allergy, University HospitalLausanne, Switzerland, NIAID HIV Vaccine
[5]
Service of Immunology and Allergy, University HospitalLausanne, Switzerland
[6]
Service of Immunology and Allergy, University HospitalLausanne, Switzerland, Swiss Vaccine Research
[7]
Service of Immunology and Allergy, University HospitalLausanne, Switzerland, EuroVacc
[8]
Vaccine Research Center, NIAID, NIHBethesda, MD, United States
[9]
Duke University Medical Center, Duke Human Vaccine InstituteDurham, NC, United States, NIAID HIV
[10]
发布时间
2015-02-04